CAM
NTRS icon

Cresset Asset Management’s Northern Trust NTRS Stock Holding History

Cresset Asset Management’s Portfolio NTRS Stock Details NTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Sell
6,002
-197
-3% -$32.5K ﹤0.01% 889
2026
Q1 		$870K Buy
6,199
+169
+3% +$24.3K ﹤0.01% 839
2025
Q4 		$828K Buy
6,030
+518
+9% +$68K ﹤0.01% 866
2025
Q3 		$746K Buy
5,512
+493
+10% +$63.4K ﹤0.01% 860
2025
Q2 		$640K Sell
5,019
-1,386
-22% -$142K ﹤0.01% 829
2025
Q1 		$637K Sell
6,405
-569
-8% -$60.4K ﹤0.01% 959
2024
Q4 		$720K Sell
6,974
-19,373
-74% -$1.98M ﹤0.01% 925
2024
Q3 		$2.39M Buy
26,347
+1,182
+5% +$103K 0.01% 717
2024
Q2 		$2.13M Buy
25,165
+10,432
+71% +$876K 0.01% 696
2024
Q1 		$1.32M Buy
14,733
+851
+6% +$69.8K 0.01% 856
2023
Q4 		$1.18M Buy
13,882
+3,437
+33% +$254K 0.01% 828
2023
Q3 		$733K Buy
10,445
+398
+4% +$30.1K ﹤0.01% 994
2023
Q2 		$752K Buy
10,047
+4,285
+74% +$329K ﹤0.01% 1071
2023
Q1 		$512K Sell
5,762
-1,341
-19% -$124K 0.01% 487
2022
Q4 		$462K Sell
7,103
-116
-2% -$10.2K 0.01% 436
2022
Q3 		$621K Sell
7,219
-422
-6% -$40.7K 0.01% 457
2022
Q2 		$737K Buy
7,641
+1,042
+16% +$110K 0.01% 443
2022
Q1 		$773K Sell
6,599
-246
-4% -$29.2K 0.01% 475
2021
Q4 		$824K Sell
6,845
-3,132
-31% -$375K 0.01% 518
2021
Q3 		$1.08M Sell
9,977
-1,415
-12% -$161K 0.01% 376
2021
Q2 		$1.32M Buy
11,392
+4,219
+59% +$484K 0.02% 286
2021
Q1 		$758K Sell
7,173
-77
-1% -$7.56K 0.01% 363
2020
Q4 		$680K Sell
7,250
-330
-4% -$29.1K 0.01% 323
2020
Q3 		$597K Sell
7,580
-389
-5% -$31.2K 0.01% 348
2020
Q2 		$638K Sell
7,969
-1,462
-16% -$116K 0.01% 294
2020
Q1 		$717K Buy
9,431
+737
+8% +$67.6K 0.02% 234
2019
Q4 		$929K Sell
8,694
-573
-6% -$58.7K 0.03% 215
2019
Q3 		$870K Sell
9,267
-154
-2% -$14.1K 0.03% 202
2019
Q2 		$853K Sell
9,421
-1,427
-13% -$131K 0.03% 193
2019
Q1 		$987K Buy
10,848
+967
+10% +$87.2K 0.04% 109
2018
Q4 		$831K Buy
+9,881
New +$926K 0.05% 87

Other funds holding NTRS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Cresset Asset Management's NTRS Position: Q2 2026 in Review

Cresset Asset Management reduced its Northern Trust (NTRS) stake by 3.2% in Q2 2026, selling an estimated $32.5K and leaving 6,002 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #889.

Cresset Asset Management first reported a position in NTRS in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.39M in Q3 2024. 1,013 funds tracked by Wall St. Rank hold NTRS as of Q2 2026.

  • Cresset Asset Management held 6,002 shares of Northern Trust worth $1.05M as of Q2 2026.
  • Cresset Asset Management sold 197 Northern Trust shares in Q2 2026, an estimated $32.5K.
  • Northern Trust made up ﹤0.01% of Cresset Asset Management's portfolio in Q2 2026, its #889 holding.
  • Cresset Asset Management first reported a position in Northern Trust in Q4 2018 and has held it in 31 quarters since.
  • Cresset Asset Management's Northern Trust position peaked at $2.39M in Q3 2024.
  • 1,013 funds tracked by Wall St. Rank held Northern Trust as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.